The Blood Markers That Actually Reflect Metabolic Health
The blood markers that actually reflect metabolic health go beyond fasting glucose.
Key takeaways
- Metabolic health is defined by a cluster of markers, not a single test. Fasting glucose alone misses early problems.
- Fasting insulin and HOMA-IR can reveal insulin resistance years before blood sugar rises, but most standard panels do not include them.
- The ratio of triglycerides to HDL cholesterol is a simple, underused proxy for insulin resistance and cardiovascular risk.
- HbA1c reflects average blood sugar over two to three months, offering a more stable view than a single fasting reading.
- Waist circumference remains one of the most practical and predictive measurements you can take at home with a tape measure.
Most annual physicals include a basic metabolic panel with fasting glucose and a lipid profile. These tests are useful, but they were designed to catch disease after it arrives, not to flag the slow metabolic drift that precedes it. By the time fasting glucose crosses the prediabetes threshold of 100 mg/dL, insulin resistance has often been building quietly for years. The markers that catch that earlier shift are available, affordable, and widely underordered.
This guide walks through the blood markers and measurements that give a more complete picture of metabolic health, explains what each one tells you, and outlines the thresholds worth knowing. If you have had an A1c test at home or are considering one, this adds context for interpreting that number alongside other results.
What metabolic health actually means
Metabolic health is not a single number. It refers to how well your body processes and distributes energy from food, particularly how efficiently it manages blood sugar, fat storage, and inflammation. The clinical definition most researchers use is the absence of metabolic syndrome, a cluster of five criteria established by the National Heart, Lung, and Blood Institute: elevated waist circumference, high triglycerides, low HDL cholesterol, high blood pressure, and elevated fasting glucose.
Meeting three or more of those five criteria qualifies as metabolic syndrome, which roughly doubles the risk of cardiovascular disease and increases the risk of type 2 diabetes fivefold. But the binary framing of “syndrome or not” obscures the fact that metabolic dysfunction is a spectrum. Someone with two criteria is not metabolically healthy just because they missed the cutoff by one. And someone with none of the five can still have early insulin resistance that standard thresholds do not flag. That is why looking at the right markers, interpreted together rather than in isolation, matters more than any single result.
Fasting glucose and why it is not enough
Fasting blood glucose is the most common metabolic marker tested in routine bloodwork. A result below 100 mg/dL is considered normal, 100 to 125 mg/dL is prediabetes, and 126 mg/dL or above on two separate occasions is diabetes. The test is simple, inexpensive, and standardized, which explains its ubiquity.
The problem is that fasting glucose is one of the last markers to change. The body has powerful compensatory mechanisms to keep blood sugar within a narrow range, primarily by producing more insulin. A person can be deeply insulin resistant, with their pancreas working overtime to maintain normal glucose, and their fasting glucose will look perfectly fine. It is only when the pancreas can no longer keep up that glucose starts to climb. By that point, years of metabolic strain have already accumulated. Fasting glucose catches the fire, not the smoke.
Fasting insulin and HOMA-IR
Fasting insulin is the marker that fills the gap fasting glucose leaves open. When cells become resistant to insulin’s signal, the pancreas compensates by producing more of it. Elevated fasting insulin, sometimes called hyperinsulinemia, is one of the earliest detectable signs of metabolic dysfunction. It can appear a decade or more before fasting glucose rises into the prediabetic range.
HOMA-IR, which stands for Homeostatic Model Assessment of Insulin Resistance, combines fasting glucose and fasting insulin into a single score using the formula: (fasting glucose in mg/dL multiplied by fasting insulin in uIU/mL) divided by 405. A HOMA-IR below 1.0 is considered optimal, below 1.5 is normal, and values above 2.0 suggest meaningful insulin resistance. Above 2.9 is often used as the clinical threshold in research. Despite its value, fasting insulin is not included in most standard metabolic panels, and many doctors do not order it unless specifically asked. If you are interested in catching metabolic drift early, requesting fasting insulin alongside your usual bloodwork is one of the most informative additions you can make.
HbA1c for the bigger picture
Hemoglobin A1c, often just called A1c, measures the percentage of hemoglobin in your red blood cells that has been glycated, meaning it has glucose attached to it. Because red blood cells live for about 90 to 120 days, A1c reflects your average blood sugar over that window rather than a single fasting snapshot. This makes it more stable and less susceptible to day-to-day variability from meals, stress, or sleep.
An A1c below 5.7% is considered normal, 5.7% to 6.4% is prediabetes, and 6.5% or above is diabetes. Within the “normal” range, there is still useful information: an A1c of 5.5% versus 5.0% may both be labeled normal, but the higher reading could indicate a trajectory worth watching, especially if paired with rising fasting insulin or increasing waist circumference. A1c is also affected by factors beyond blood sugar, including red blood cell turnover, iron deficiency, and certain hemoglobin variants, which your doctor can account for when interpreting results.
Triglycerides and the TG-to-HDL ratio
Most people know their total cholesterol and LDL numbers because those are the ones typically discussed at annual visits. But for metabolic health specifically, triglycerides and HDL cholesterol, and the ratio between them, are often more informative. Elevated triglycerides, particularly above 150 mg/dL, are closely associated with insulin resistance and are one of the five metabolic syndrome criteria. Low HDL, below 40 mg/dL for men and 50 mg/dL for women, is another.
The triglyceride-to-HDL ratio takes both into account in a single number and has emerged in research as a practical, inexpensive proxy for insulin resistance. A ratio below 1.0 is considered ideal, below 2.0 is good, and above 3.0 is associated with significant insulin resistance and increased cardiovascular risk. In some studies, this ratio has performed comparably to HOMA-IR in predicting metabolic outcomes. It has the advantage of being calculated from standard lipid panels that most adults get annually, meaning you may already have the data to compute it without ordering additional tests.
Waist circumference and metabolic syndrome
Waist circumference is not a blood marker, but it deserves a place in any discussion of metabolic health because it is one of the strongest predictors of metabolic syndrome, cardiovascular risk, and type 2 diabetes, independent of BMI. Visceral fat, the fat stored around internal organs in the abdomen, is metabolically active tissue that drives inflammation and insulin resistance in ways that subcutaneous fat does not.
The thresholds used in the metabolic syndrome definition are 40 inches (102 cm) or more for men and 35 inches (88 cm) or more for women, though some guidelines use lower cutoffs for certain ethnic groups. Measuring is simple: wrap a tape measure around your bare abdomen at the level of your navel, standing, after a normal exhale. It takes 10 seconds and requires no lab order. If your waist circumference is creeping upward over time, that trend is worth paying attention to even if every blood marker looks fine. It often changes before the labs do.
Putting the numbers together
No single marker tells the full story, and no single abnormal result means you have a problem. The value of these markers is in the pattern they form together. A fasting glucose of 95 mg/dL looks normal in isolation but takes on different meaning if fasting insulin is 18 uIU/mL, triglycerides are 180 mg/dL, and waist circumference has increased by three inches over two years. That combination describes early metabolic dysfunction that standard screening would label “normal” because no single number crossed a threshold.
If you want a more complete picture, the most practical step is to ask your doctor to add fasting insulin to your next routine blood draw. It is inexpensive and widely available. From there, you can calculate HOMA-IR and the TG-to-HDL ratio yourself. Combined with A1c and a tape measure, these give you a metabolic dashboard that is far more informative than fasting glucose alone. Track trends over time rather than fixating on any single reading, and bring the results to a clinician who can interpret them in context.
Frequently asked questions
Can I request fasting insulin from my doctor?
Yes. Fasting insulin is a standard lab test that any doctor can order. It is not always included in routine panels, so you may need to ask for it specifically. Some direct-to-consumer lab services also offer it without a doctor’s order, though having a clinician interpret the result in context is recommended.
What is a normal fasting insulin level?
Optimal fasting insulin is generally considered to be below 5 to 7 uIU/mL, though many labs list the “normal” reference range as up to 25 uIU/mL. That upper bound captures a wide range of insulin resistance as “normal,” which is why HOMA-IR, which combines insulin with glucose, gives a more nuanced picture. A fasting insulin consistently above 10 uIU/mL warrants attention.
How often should I check these markers?
For most adults, annual testing is sufficient unless you or your doctor have identified a trend worth watching more closely. If you are actively making lifestyle changes to improve metabolic health, rechecking at three to six months can show whether those changes are moving the numbers in the right direction.
Does metabolic syndrome always lead to diabetes?
No. Metabolic syndrome increases the risk of type 2 diabetes significantly, but it is not a guarantee. Many people with metabolic syndrome never develop diabetes, particularly if they make sustained lifestyle changes such as improving diet quality, increasing physical activity, and reducing visceral fat. The syndrome identifies risk, not destiny.
Is BMI or waist circumference a better predictor of metabolic risk?
For metabolic health specifically, waist circumference is generally a better predictor than BMI. BMI does not distinguish between muscle and fat or between subcutaneous and visceral fat. A person with a normal BMI but a large waist circumference, sometimes called “normal-weight obesity” or “TOFI” (thin outside, fat inside), can carry significant metabolic risk that BMI alone would miss.
This article is for educational purposes only and is not medical advice. Consult a qualified healthcare professional for personalized guidance on testing and treatment.
